首页> 美国卫生研究院文献>other >Oral Administration of a Fusion Protein between the Cholera Toxin B Subunit and the 42-Amino Acid Isoform of Amyloid-β Peptide Produced in Silkworm Pupae Protects against Alzheimers Disease in Mice
【2h】

Oral Administration of a Fusion Protein between the Cholera Toxin B Subunit and the 42-Amino Acid Isoform of Amyloid-β Peptide Produced in Silkworm Pupae Protects against Alzheimers Disease in Mice

机译:蚕Administration中产生的霍乱毒素B亚基和淀粉样β肽的42个氨基酸同工型之间融合蛋白的口服给药可预防小鼠阿尔茨海默氏病

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A key molecule in the pathogenesis of Alzheimer's disease (AD) is a 42-amino acid isoform of the amyloid-β peptide (Aβ42), which is the most toxic element of senile plaques. In this study, to develop an edible, safe, low-cost vaccine for AD, a cholera toxin B subunit (CTB)-Aβ42 fusion protein was successfully expressed in silkworm pupae. We tested the silkworm pupae-derived oral vaccination containing CTB-Aβ42 in a transgenic mouse model of AD. Anti-Aβ42 antibodies were induced in these mice, leading to a decreased Aβ deposition in the brain. We also found that the oral administration of the silk worm pupae vaccine improved the memory and cognition of mice, as assessed using a water maze test. These results suggest that the new edible CTB-Aβ42 silkworm pupae-derived vaccine has potential clinical application in the prevention of AD.
机译:阿尔茨海默氏病(AD)发病机理中的关键分子是淀粉样β肽(Aβ42)的42个氨基酸同工型,这是老年斑中毒性最高的元素。在这项研究中,为开发可食用,安全,低成本的AD疫苗,霍乱毒素B亚基(CTB)-Aβ42融合蛋白已在蚕worm中成功表达。我们在AD的转基因小鼠模型中测试了含有CTB-Aβ42的家蚕衍生的口服疫苗。在这些小鼠中诱导出抗Aβ42抗体,导致大脑中Aβ沉积减少。我们还发现,使用水迷宫测试评估,口服蚕p疫苗可改善小鼠的记忆力和认知能力。这些结果表明,新的可食用的CTB-Aβ42家蚕p疫苗在预防AD中具有潜在的临床应用。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号